Viewing Study NCT02604433

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-02-23 @ 8:56 PM
Study NCT ID: NCT02604433
Status: COMPLETED
Last Update Posted: 2023-04-18
First Post: 2015-10-21
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia
Sponsor: Celgene
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Erythrocyte Transfusion View
None Beta-Thalassemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ACE-536 View
None Safety View
None Efficacy View
None Placebo View
None Red Blood Cell Transfusions View
None Beta -Thalassemia View